title: Analytical toxicology of emerging drugs of abuse--an update.
abstract: The steady increase of new drugs of abuse on the illicit drug market is a great challenge for analytical toxicologists. Because most of these new drugs or drug classes are not included in established analytical methods targeting classic drugs of abuse, analytical procedures must be adapted or new procedures must be developed to cover such new compounds. This review summarizes procedures for analysis of these drugs of abuse published from January 2009 to January 2012 covering the following classes of emerging drugs of abuse as follows: β-keto-amphetamines, pyrrolidinophenones, tryptamines, and synthetic cannabinoids.
authors.affiliation: Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Saarland University, Homburg, Germany. markus.meyer@uks.eu
authors.forename: Markus R
authors.initials: MR
authors.lastname: Meyer
authors.forename: Frank T
authors.initials: FT
authors.lastname: Peters
mesh_terms: D000818:Animals; D015198:Designer Drugs / Q000032:analysis* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000633:toxicity; D006801:Humans; D013287:Illicit Drugs / Q000032:analysis* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000633:toxicity; D015813:Substance Abuse Detection / Q000639:trends*; D019966:Substance-Related Disorders / Q000097:blood / Q000175:diagnosis* / Q000652:urine
chemical_list: D015198:Designer Drugs; D013287:Illicit Drugs